medigraphic.com
ISSN 1561-2988 (Impreso)

2020, Número 4

<< Anterior Siguiente >>

Rev Cubana Farm 2020; 53 (4)


Brote de enfermedad por el virus del Ébola: enfoque global para el sistema de salud

Alvarez-Risco A, Dawson J, Johnson W, Conteh-Barrat M, Aslani P, Del-Aguila-Arcentales S, Diaz-Risco S

Idioma: Ingles.
Referencias bibliográficas: 31
Paginas: 1-11
Archivo PDF: 740.34 Kb.


RESUMEN

Introducción: La enfermedad por el virus del Ébola es grave, muy infecciosa y, a menudo, mortal. La experiencia de los farmacéuticos en Sierra Leona en el enfrentamiento al ébola es valiosa para que otros países aprendan de estas prácticas y pueda haber un beneficio a nivel global.
Objetivo: Describir las tareas desarrolladas en Sierra Leona durante el brote del Ébola.
Métodos: Se trata de una revisión documental basada en la normativa desarrollada y los documentos técnicos publicados por el Ministerio de Salud de Sierra Leona.
Conclusiones: Los sistemas de salud necesitan un trabajo colaborativo, especialmente en casos de epidemias o pandemias. La información presentada muestra lo que se podría lograr en la epidemia del Ébola, para detectar focos emergentes, comunicación entre profesionales y salvar vidas. Este aprendizaje debe ser utilizado en el caso de COVID-19 donde se requiere la interconexión entre profesionales y autoridades sanitarias, información veraz y ágil hacia la población y avances coordinados para obtener los mejores tratamientos para los pacientes.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Alvarez-Risco A, Mejia CR, Delgado-Zegarra J, Del-Aguila-Arcentales S, Arce-Esquivel AA, Valladares-Garrido MJ, et al. The Peru Approach against the COVID-19 Infodemic: Insights and Strategies. The American Journal of Tropical Medicine and Hygiene. 2020;103(2):583-6. DOI: 10.4269/ajtmh.20-0536

  2. Yáńez JA, Alvarez-Risco A, Delgado-Zegarra J. Covid-19 in Peru: from supervised walks for children to the first case of Kawasaki-like syndrome. BMJ (Clinical research ed.). 2020;369: m2418. DOI: 10.1136/bmj.m2418

  3. Rojas Román B, Moscoso S, Chung S, Limpias Terceros B, Álvarez-Risco A, Yáńez JA. Tratamiento de la COVID-19 en Perú y Bolivia y los riesgos de la automedicación. Rev Cubana Farm. 2020 [cited 12/12/2020];53(2). Available from: http://www.revfarmacia.sld.cu/index.php/far/article/view/435

  4. Mejía-Acosta N, Alvarez-Risco A, Solís-Tarazona Z, Matos-Valerio E, Zegarra-Arellano E, Del-Aguila-Arcentales S. Adverse Drug Reactions reported as a result of the implementation of Pharmaceutical Care in the Institutional Pharmacy DIGEMID - Ministry of Health of Peru. Pharm Care. Esp. 2013;18 (2): 67-74.

  5. Alvarez-Risco A, Del-Aguila-Arcentales S, Diaz-Risco S. Pharmacovigilance as a tool for sustainable development of healthcare in Peru. Pharmacovigilance review. 2018 [cited 12/12/2020];10(2),4-6. Available from: https://www.scopus.com/record/display.uri?eid=2- s2.0-85075346517&origin=inward&txGid=f3d889d9dded0bb7f1124aa4ee835413

  6. Alvarez-Risco A, Turpo-Cama A, Ortiz-Palomino L, Gongora-Amaut N, Del-Aguila- Arcentales S. Barriers for the implementation of Pharmaceutical Care in pharmaceutical establishments in Cusco, Peru. Pharm Care Esp. 2016 [cited 12/12/2020];18(5):194-205. Available from https://www.pharmcareesp.com/index.php/PharmaCARE/article/view/326/263

  7. Yáńez JA, Afshar Jahanshahi A, Alvarez-Risco A, Li J, Zhang SX. The anxiety, distress and turnover intention of healthcare workers in Peru by their distance to the epicenter during the COVID-19 crisis. The American Journal of Tropical Medicine and Hygiene. 2020 [cited 12/12/2020];103(4):1614-20. Available from http://www.ajtmh.org/docserver/fulltext/14761645/103/4/tpmd200800.pdf?expires=16077 85533&id=id&accname=guest&checksum=0C59A61A839F0A41BDF67779A9A38099

  8. Chen X, Zhang SX, Jahanshahi AA, Alvarez-Risco A, Dai H, Li J, Ibarra VG. Belief in a COVID-19 Conspiracy Theory as a Predictor of Mental Health and Well-Being of Health Care Workers in Ecuador: Cross-Sectional Survey Study. JMIR Public Health and Surveillance. 2020;6(3):e20737. DOI: 10.2196/20737

  9. Zhang SX, Sun S, Jahanshahi AA, Alvarez-Risco A, Ibarra VG, Li J, Patty-Tito RM. Developing and testing a measure of COVID-19 Organizational Support of Healthcare Workers – Results from Peru, Ecuador, and Bolivia. Psychiatry Research. 2020;291:113174. DOI: 10.1016/j.psychres.2020.113174

  10. Gatherer D. The 2014 Ebola virus disease outbreak in West Africa. J Gen Virol. 2014;95(Pt 8):1619-24. DOI: 10.1099/vir.0.067199-0

  11. Turn S, Goba A, Andersen K, Sealfon R, Park D, Kanneh L. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science. 2014;345 (6202):1369-72. DOI: 10.1126/science.1259657

  12. Alexander K, Sanderson C, Marathe M, Lewis B, Rivers C, Shaman J. What factors might have led to the emergence of ebola in West Africa? PLoS Negl Trop Dis. 2015;9(6):e0003652. DOI: 10.1371/journal.pntd.0003652

  13. Farrar J, Piot P. The Ebola emergency-immediate action, ongoing strategy. N Engl J Med. 2014;371 (16): 1545-6. DOI: 10.1056/NEJMe1411471

  14. Park D, Doubts G, Wohl S, Goba A, Whitmer S, Andersen K. Ebola virus epidemiology, transmission, and evolution during seven months in Sierra Leone. Cell. 2015;161 (7):1516- 26. DOI: 10.1016/j.cell.2015.06.007

  15. Mäkelä T, Annila A. Natural patterns of energy dispersal. Phys Life Rev. 2010;7(4):477- 98. DOI: 10.1016/j.plrev.2010.10.001

  16. FIP. Ebola. [cited 2019/12/01]. Available from: http://www.fip.org/ebola.

  17. Karan A, Pogge T. Ebola and the need for restructuring pharmaceutical incentives. Journal of Global Health. 2015;5(1):010303. DOI: 10.7189/jogh.05.010303

  18. Roemer-Mahler A, Elbe S. The race for Ebola drugs: pharmaceuticals, security and global health governance, Third World Quarterly. 2016;37:3:487-50. DOI: 10.1080/01436597.2015.1111136

  19. IFPMA. Tackling global health challenges. Ebola. [cited 2020/10/05]. Available from: https://www.ifpma.org/subtopics/ebola/

  20. CDC. Ebola diagnosis. EE. UU.: CDC; [2019] [cited 2019/12/20]. Available from: http://www.cdc.gov/vhf/ebola/diagnosis/index.html

  21. CDC. Ebola prevention. EE. UU.: CDC; [2019] [cited 2019/11/15]. Available from: http://www.cdc.gov/vhf/ebola/prevention

  22. Varkey JB, Shantha JG, Crozier I, Kraft CS, Lyon GM, Mehta AK, et al. Persistence of Ebola Virus in Ocular Fluid during Convalescence. N Engl J Med. 2015;372(25):2423-27. DOI: 10.1056/NEJMoa1500306

  23. BBC News. Sierra Leona. Set to be Declared Free from Ebola. [cited 2019/11/20]. Available from: http://www.bbc.co.uk/programmes/p036hn82

  24. WHO. Ebola Situation Reports. [cited 2019/12/20]. Available from: http://apps.who.int/ebola/ebola-situation-reports.

  25. Johnson WC. New Medicines and Vaccines Monitoring Safety In Emergency Situations A Developing Country Experience. Theories, Facts And Realities; 2012 [cited 2020/10/10]. Available from: http://www.ehas.org/wp-content/uploads/2012/09/MemoriaMartaVila.pdf

  26. USAID. Use of technology in the ebola response in West Africa. Technical Brief; 2014 [cited 2019/12/13]. Available from: https://www.msh.org/sites/msh.org/files/technology_and_ebola_response_in_west_africa_t echnical_brief_final.pdf

  27. Manya A, Braa J, Řverland L Titlesta O, Mumo J, Nzioka C. Implementation of District Health Information Software 2 (DHIS2) in Sri Lanka. Sri Lanka Journal of Bio-Medical Informatics. 2012;3(4):109-14. Available from https://pdfs.semanticscholar.org/972f/6e7d29cdb521cbf68b6f3a98233c7b819c75.pdf?_ga= 2.119800333.406545103.1607787884-848177293.1606784169

  28. Karuri J, Waiganjo P, Orwa D, Mayna A. DHIS2: The Tool to Improve Health Data Demand and Use in Kenya. Journal of Health Informatics in Developing Countries. 2014 [cited 2019/12/13];8(1):38-60. Availabe from: https://www.jhidc.org/index.php/jhidc/article/view/113/154

  29. Vila-Pozo MM, Martinez-Fernandez A. Feasibility study for the improvement of health information system of rural establishments in Peru (Case Study Region of Loreto) using tool DHIS2. [Estudio de viabilidad para la mejora del sistema de información de salud de los establecimientos rurales de Perú (caso de estudio región de Loreto) utilizando la herramienta DHIS2]. [master's thesis]. [Perú]: Universidad Rey Juan Carlos; 2012 [cited 2019/11/19]. Available from: https://burjcdigital.urjc.es/bitstream/handle/10115/8122/PFM_MartaVila.pdf?sequence=1 &isAllowed=y

  30. Iyengar P, Kerber K, Howe CJ, Dahn B. Services for Mothers and Newborns During the Ebola Outbreak in Liberia: The Need for Improvement in Emergencies. PLoS Currents. 2015 [cited 2019/12/21];7. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404271/

  31. UNICEF. RapidPro: Enhancing communication with those who matter most. [cited 2019/12/23]. Available from: http://www.unicefstories.org/2015/05/05/rapidpro-enhancingcommunication-with-those-who-matter-most/




2020     |     www.medigraphic.com